Interestingly, this was only statistically significant in MYCN ON cells (Mann–Whitney U p<0.05), suggesting that although olaparib is having similar effects on fork progression in the presence or absence of MYCN, the overall effect of PARP inhibition on replication is greater when NB cells express MYCN. Here, PARP1 is linked to neuroblastoma.